Human TRAIL R2/TNFRSF10B PE-conjugated Antibody
R&D Systems, part of Bio-Techne | Catalog # FAB6311P
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Ile56-Glu182
Accession # O14763
Specificity
Clonality
Host
Isotype
Scientific Data Images for Human TRAIL R2/TNFRSF10B PE-conjugated Antibody
MDA‑MB‑231 Human Cell Line by Flow Cytometry.
MDA-MB-231 human breast cancer cell line was stained with Mouse Anti-Human TRAIL R2/TNFRSF10B PE-conjugated Monoclonal Antibody (Catalog # FAB6311P, filled histogram) or isotype control antibody (Catalog # IC0041P, open histogram). View our protocol for Staining Membrane-associated Proteins.Detection of TRAIL R2/TNFRSF10B by Western Blot
Knockdown of K8 enhances TRAIL induced apoptosis(A-C) Cells were transfected with a control siRNA or siRNA specific to KRT8 transcript for 72 hours, followed by TRAIL stimulation (100 ng/ml [T47D and BT474] or 150 ng/ml [MCF7]) for 24 hours. The resultant cells were analyzed by immunoblotting using antibodies specific to K8/K18, DR4, DR5, caspase-3, caspase-8, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Caspase activation was identified by decrease in pro-enzyme form (ProC-8 and ProC-3). (D-F) Cells were treated as above and analyzed by flow cytometry after staining with Annexin-V-FITC and propidium iodide (PI). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/29796187), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of TRAIL R2/TNFRSF10B by Western Blot
Keratin 8/18 overexpression downregulates total DR5 protein levels(A) MDA-MB-231 cells were transfected with a control plasmid or plasmid encoding human keratin 18 for 24 hours, followed by TRAIL stimulation (0, 5, 10 ng/ml) for 3 hours. The resultant cells were analyzed by immunoblotting using antibodies against K8/K18, DR5, DR4, caspase-8, caspase-3, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Caspase activation is indicated by a decrease in pro-enzyme form (ProC-8 and ProC-3) and by the simultaneous appearance of cleaved fragments. Results are from non-adjoining lanes from the same gel. (B) Relative total DR5 and DR4 protein levels were quantified using densitometry analysis of immunoblots in A and were normalized to GAPDH loading controls. P-values were determined using a student’s t-test. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/29796187), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Human TRAIL R2/TNFRSF10B PE-conjugated Antibody
Flow Cytometry
Sample: MDA‑MB‑231 human breast cancer cell line
Reviewed Applications
Read 1 review rated 4 using FAB6311P in the following applications:
Formulation, Preparation, and Storage
Purification
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, 2 to 8 °C as supplied.
Background: TRAIL R2/TNFRSF10B
Human TRAIL R2, also known as DR5 and TRICK 2, is a type 1, TNF R family, transmembrane protein which is a receptor for TRAIL (APO2 Ligand). In the new TNF superfamily nomenclature, TRAIL R2 is referred to as TNFRSF10B. TRAIL R2 cDNA encodes a 440 amino acid residue precursor protein containing extracellular cysteine-rich domains, a transmembrane domain and a cytoplasmic death domain. Among TNF receptor family proteins, TRAIL R2 is most closely related to TRAIL R1/DR4, sharing 55% amino acid sequence identity. Binding of trimeric TRAIL to TRAIL R2 induces apoptosis. The induction of apoptosis likely requires oligomerization of the receptor. The human TRAIL R2/Fc chimera neutralizes the ability of TRAIL to induce apoptosis. Besides TRAIL R2, an additional TRAIL R1/DR4, which tranduces apoptosis signaling, and two TRAIL decoy receptors, which antagonize TRAIL-induced apoptosis, have been reported.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional TRAIL R2/TNFRSF10B Products
Product Documents for Human TRAIL R2/TNFRSF10B PE-conjugated Antibody
Product Specific Notices for Human TRAIL R2/TNFRSF10B PE-conjugated Antibody
For research use only